190 related articles for article (PubMed ID: 28743508)
41. Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials.
Matralis AN; Afantitis A; Aidinis V
Med Res Rev; 2019 May; 39(3):976-1013. PubMed ID: 30462853
[TBL] [Abstract][Full Text] [Related]
42. Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model.
Lei H; Li Z; Li T; Wu H; Yang J; Yang X; Yang Y; Jiang N; Zhai X
Bioorg Chem; 2022 Mar; 120():105590. PubMed ID: 34998121
[TBL] [Abstract][Full Text] [Related]
43. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors.
Vrontaki E; Melagraki G; Kaffe E; Mavromoustakos T; Kokotos G; Aidinis V; Afantitis A
Curr Med Chem; 2016; 23(17):1708-24. PubMed ID: 26997151
[TBL] [Abstract][Full Text] [Related]
44. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and promising anti-tumor efficacy of novel imidazo[1,2-a]pyridine derivatives as potent autotaxin allosteric inhibitors.
Lei H; Wang X; Zhao G; Li T; Cui Y; Wu H; Yang J; Jiang N; Zhai X
Eur J Med Chem; 2022 Jun; 236():114307. PubMed ID: 35436669
[TBL] [Abstract][Full Text] [Related]
46. Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes.
Stylianaki EA; Mouchlis VD; Magkrioti C; Papavasileiou KD; Afantitis A; Matralis AN; Aidinis V
Bioorg Med Chem Lett; 2024 May; 103():129690. PubMed ID: 38447786
[TBL] [Abstract][Full Text] [Related]
47. Discovery of Novel Indole-Based Allosteric Highly Potent ATX Inhibitors with Great
Lei H; Guo M; Li X; Jia F; Li C; Yang Y; Cao M; Jiang N; Ma E; Zhai X
J Med Chem; 2020 Jul; 63(13):7326-7346. PubMed ID: 32479084
[TBL] [Abstract][Full Text] [Related]
48. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.
Magkrioti C; Kaffe E; Stylianaki EA; Sidahmet C; Melagraki G; Afantitis A; Matralis AN; Aidinis V
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977539
[TBL] [Abstract][Full Text] [Related]
49. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling.
Keune WJ; Hausmann J; Bolier R; Tolenaars D; Kremer A; Heidebrecht T; Joosten RP; Sunkara M; Morris AJ; Matas-Rico E; Moolenaar WH; Oude Elferink RP; Perrakis A
Nat Commun; 2016 Apr; 7():11248. PubMed ID: 27075612
[TBL] [Abstract][Full Text] [Related]
50. Green Synthesis and Molecular Docking of Thiazolyl-thiazole Derivatives as Potential Cytotoxic Agents.
Gomha SM; Abdelaziz MR; Abdel-Aziz HM; Hassan SA
Mini Rev Med Chem; 2017; 17(9):805-815. PubMed ID: 28019641
[TBL] [Abstract][Full Text] [Related]
51. Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents.
Anuradha ; Patel S; Patle R; Parameswaran P; Jain A; Shard A
Eur J Pharm Sci; 2019 Jun; 134():20-30. PubMed ID: 30965082
[TBL] [Abstract][Full Text] [Related]
52. Design and discovery of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives as cardiotonic agents via inhibition of PDE3.
Duan LM; Yu HY; Li YL; Jia CJ
Bioorg Med Chem; 2015 Sep; 23(18):6111-7. PubMed ID: 26319621
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase.
Zhu J; Han L; Diao Y; Ren X; Xu M; Xu L; Li S; Li Q; Dong D; Huang J; Liu X; Zhao Z; Wang R; Zhu L; Xu Y; Qian X; Li H
J Med Chem; 2015 Feb; 58(3):1123-39. PubMed ID: 25580811
[TBL] [Abstract][Full Text] [Related]
55. Virtual screening approaches for the identification of non-lipid autotaxin inhibitors.
Parrill AL; Echols U; Nguyen T; Pham TC; Hoeglund A; Baker DL
Bioorg Med Chem; 2008 Feb; 16(4):1784-95. PubMed ID: 18036821
[TBL] [Abstract][Full Text] [Related]
56. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
Ismail MA; Tratrat C; Haroun MG
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
Liu S; Shang R; Shi L; Wan DC; Lin H
Eur J Med Chem; 2014 Jun; 81():237-44. PubMed ID: 24844448
[TBL] [Abstract][Full Text] [Related]
58. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Choi SP; Kim TH; Jung CK; Lee JY; Jung SH; Kim GT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1254-8. PubMed ID: 25704891
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.
Zhou M; Ning C; Liu R; He Y; Yu N
Bioorg Med Chem Lett; 2013 Jun; 23(11):3200-3. PubMed ID: 23639537
[TBL] [Abstract][Full Text] [Related]
60. Discovery and optimization of boronic acid based inhibitors of autotaxin.
Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
